A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for Chronic Kidney Disease and Hypertension
Drug: Dapagliflozin
Sites in Kansas City, Wichita +115 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06742723·Phase 3·Recruiting·Listed Dec 2024